id stringlengths 40 40 | source stringclasses 9
values | title stringlengths 2 345 | clean_text stringlengths 35 1.63M | raw_text stringlengths 4 1.63M | url stringlengths 4 498 | overview stringlengths 0 10k |
|---|---|---|---|---|---|---|
01c2a7dd3be57b557d919b6046345be4e40f9a1d | wikidoc | Elvitegravir cobicistat emtricitabine tenofovir warnings and precautions | Elvitegravir cobicistat emtricitabine tenofovir warnings and precautions
# Warnings and Precautions
## Lactic Acidosis/Severe Hepatomegaly with Steatosis
Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogs, including tenofovir DF, a comp... | Elvitegravir cobicistat emtricitabine tenofovir warnings and precautions
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
# Warnings and Precautions
## Lactic Acidosis/Severe Hepatomegaly with Steatosis
Lactic acidosis and severe hepatomegaly with steatosi... | https://www.wikidoc.org/index.php/Elvitegravir_cobicistat_emtricitabine_tenofovir_warnings_and_precautions | |
5a2aed9f7f2780763eccdb89ff2dddb261b36cf4 | wikidoc | Stent thrombosis relationship to discontinuation of antiplatelet therapy | Stent thrombosis relationship to discontinuation of antiplatelet therapy
# Relationship to Discontinuation of Antiplatelet Therapy
## Incidence Of Premature Discontinuation Of Antiplatelet Therapy
In a prospective study analyzing 1622 patients who received at least one DES, 14.4% discontinued at least 1 antiplatelet ... | Stent thrombosis relationship to discontinuation of antiplatelet therapy
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Smita Kohli, M.D.; Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.
# Relationship to Discontinuation of Antiplatelet Therapy
## Incidence Of Premature Disc... | https://www.wikidoc.org/index.php/Incidence_of_drug_eluting_stent_thrombosis_(ST)_in_relation_to_antiplatelet_medication_use | |
015d007135c8a95bb54924a15875ab1219b30bd8 | wikidoc | Arrhythmogenic right ventricular cardiomyopathy resident survival guide | Arrhythmogenic right ventricular cardiomyopathy resident survival guide
# Overview
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disease characterized by myocyte loss and fibro-fatty tissue replacement of the right ventricular myocardium. This puts patients into risk of life-threatening ventricul... | Arrhythmogenic right ventricular cardiomyopathy resident survival guide
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Steven Bellm, M.D. [2]
# Overview
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disease characterized by myocyte loss and fibro-fatty tissue replacement of the right ventri... | https://www.wikidoc.org/index.php/Arrhythmogenic_right_ventricular_cardiomyopathy_resident_survival_guide | |
1d78399d9c8c56f25b8d5f1a408fe7c33ad49a2b | wikidoc | Echo in pericardial diseases: effusion, cardiac tamponade, constriction | Echo in pericardial diseases: effusion, cardiac tamponade, constriction
# 2D Echocardiography: Pericardial Effusions/Tamponade
# Basic Principles
In normal pericardium, there is approximately 30 to 50 mL of fluid between the visceral and parietal pericardium. This amount of fluid usually is not visible on ultrasound.... | Echo in pericardial diseases: effusion, cardiac tamponade, constriction
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor: Cafer Zorkun, M.D., Ph.D. [2]
# 2D Echocardiography: Pericardial Effusions/Tamponade
# Basic Principles
In normal pericardium, there is approximately 30 to 50 mL of fluid be... | https://www.wikidoc.org/index.php/Echo_in_pericardial_diseases:_effusion,_cardiac_tamponade,_constriction | |
026c2da01ddb2396434d88e1bfb5efcbf5c6f43b | wikidoc | Heparin Flush Injection 10 units/mL, 100 units/mL (patient information) | Heparin Flush Injection 10 units/mL, 100 units/mL (patient information)
# About your treatment
Your doctor has ordered heparin flush, an anticoagulant ('blood thinner'), to prevent the formation of clots that could block your intravenous (IV) catheter.
You will probably use heparin flush several times a day. Your heal... | Heparin Flush Injection 10 units/mL, 100 units/mL (patient information)
Template:Drug header
# About your treatment
Your doctor has ordered heparin flush, an anticoagulant ('blood thinner'), to prevent the formation of clots that could block your intravenous (IV) catheter.
You will probably use heparin flush several ... | https://www.wikidoc.org/index.php/Heparin_Flush_Injection_10_units/mL,_100_units/mL | |
a530f75d104924da524880849848b75e502056d8 | wikidoc | Progressive encephalopathy with edema, hypsarrhythmia and optic atrophy | Progressive encephalopathy with edema, hypsarrhythmia and optic atrophy
Synonyms and keywords: Infantile cerebello optic atrophy ; PEHO syndrome
# Overview
PEHO (Progressive encephalopathy with Edema, Hypsarrhythmia and Optic atrophy) syndrome is a rare neurodegenerative disorder belonging to the group of infantile p... | Progressive encephalopathy with edema, hypsarrhythmia and optic atrophy
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Infantile cerebello optic atrophy ; PEHO syndrome [1]
# Overview
PEHO (Progressive encephalopathy with Edema, Hypsarrhythmia and Optic atrophy) syndrome is a rare neurodege... | https://www.wikidoc.org/index.php/Infantile_cerebello_optic_atrophy | |
ebe00e4c8b07493c5d46a19871a974179e6d3fd1 | wikidoc | Natural Orifice Surgery Consortium for Assessment and Research (NOSCAR) | Natural Orifice Surgery Consortium for Assessment and Research (NOSCAR)
For the WikiPatient page for this topic, click here
Synonyms and keywords: Natural orifice translumenal endoscopic surgery, Single incision laparoscopic surgery, Minimally invasive surgery, Transanal endoscopic microsurgery, Natural orifice surgery... | Natural Orifice Surgery Consortium for Assessment and Research (NOSCAR)
For the WikiPatient page for this topic, click here
Editor-In-Chief: Mohammed A. Sbeih, M.D. [1]Phone: 617-849-2629; Assistant Editor-In-Chief: Kristin Feeney, B.S. [2]
Synonyms and keywords: Natural orifice translumenal endoscopic surgery, Single... | https://www.wikidoc.org/index.php/Natural_Orifice_Surgery_Consortium_for_Assessment_and_Research_(NOSCAR) | |
dffa5337c99619ee09e1dfac06c2518f35d02128 | wikidoc | Polyethylene glycol-electrolyte solution (PEG-ES) (patient information) | Polyethylene glycol-electrolyte solution (PEG-ES) (patient information)
# Why is this medication prescribed
Polyethylene glycol-electrolyte solution (PEG-ES) is used to cleanse the bowel before a gastrointestinal examination or surgery. It works by causing diarrhea.
This medication is sometimes prescribed for other us... | Polyethylene glycol-electrolyte solution (PEG-ES) (patient information)
Template:Drug header
# Why is this medication prescribed
Polyethylene glycol-electrolyte solution (PEG-ES) is used to cleanse the bowel before a gastrointestinal examination or surgery. It works by causing diarrhea.
This medication is sometimes p... | https://www.wikidoc.org/index.php/Polyethylene_glycol-electrolyte_solution_(PEG-ES)_(patient_information) | |
06786c0c9805ac551df56d817b2e0eb933502126 | wikidoc | TRANSCEND Study suggests that telmisartan reduces cardiovascular events | TRANSCEND Study suggests that telmisartan reduces cardiovascular events
August 31, 2008 by Scott P. Williams
ESC Congress 2008- Munich, DE: Researchers from McMaster University reported that the angiotensin-receptor blocker (ARB), telmisartan, while well tolerated by patients and associated with a modest reduction in... | TRANSCEND Study suggests that telmisartan reduces cardiovascular events
August 31, 2008 by Scott P. Williams [1]
ESC Congress 2008- Munich, DE: Researchers from McMaster University reported that the angiotensin-receptor blocker (ARB), telmisartan, while well tolerated by patients and associated with a modest reductio... | https://www.wikidoc.org/index.php/TRANSCEND_Study_suggests_that_telmisartan_reduces_cardiovascular_events | |
703aa03df0ee44f6ce66d37e4ea4485386271611 | wikidoc | T wave alternans for risk stratification during exercise stress testing | T wave alternans for risk stratification during exercise stress testing
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
# Overview
Across the past decade, a sizeable body of evidence has been amassed indicating that measurement of T wave alternans (TWA), a beat-to-beat fluctuation in the morph... | T wave alternans for risk stratification during exercise stress testing
Editors-In-Chief: Kapil Kumar, M.D., Ernest Gervino, Sc.D., Bruce D. Nearing, Ph.D., Richard L. Verrier, Ph.D.
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
# Overview
Across the past decade, a sizeable body of evidence... | https://www.wikidoc.org/index.php/T_Wave_Alternans_for_Risk_Stratification_during_Exercise_Stress_Testing | |
50d293f5042fd0c9f722af6736e36f487211d343 | wikidoc | Acute mesenteric ischemia natural history, complications and prognosis | Acute mesenteric ischemia natural history, complications and prognosis
# Overview
Acute mesenteric ischemia is an emergency that is associated with high rate of mortality as the treatment id delayed. The early initiation of treatment is associated with low mortality rate ranging from 0 to 10%; whereas delayed treatmen... | Acute mesenteric ischemia natural history, complications and prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby
# Overview
Acute mesenteric ischemia is an emergency that is associated with high rate of mortality as the treatment id delayed. The early initiation of ... | https://www.wikidoc.org/index.php/Acute_mesenteric_ischemia_natural_history,_complications_and_prognosis | |
7a2744e26578f4586751bb7545d8165df5f1944e | wikidoc | The Living Guidelines: Diagnosis and Management of Atrial Fibrillation | The Living Guidelines: Diagnosis and Management of Atrial Fibrillation
# Recommendations for pharmacological rate control during atrial fibrillation
## Class I
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
## Class... | The Living Guidelines: Diagnosis and Management of Atrial Fibrillation
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please ... | https://www.wikidoc.org/index.php/Atrial_fibrillation_guidelines | |
3efe8c9b96ad17f37baa577b9c21140418e06340 | wikidoc | Clinical event adjudication: Unstable angina requiring hospitalization | Clinical event adjudication: Unstable angina requiring hospitalization
For the list of clinical event adjudication definitions, click here
This chapter presents unstable angina requiring hospitalization definitions used in the Clinical Event Committee adjudication processes. These definitions are current as of 3/26/10.... | Clinical event adjudication: Unstable angina requiring hospitalization
For the list of clinical event adjudication definitions, click here
Editors-in-Chief: C. Michael Gibson, M.S., M.D. [1]
This chapter presents unstable angina requiring hospitalization definitions used in the Clinical Event Committee adjudication pr... | https://www.wikidoc.org/index.php/Clinical_event_adjudication:_Unstable_angina_requiring_hospitalization | |
36c289390c2880a7e8b191018ae4d1f3600cc843 | wikidoc | Family with sequence similarity 19 member A4, C-C motif chemokine like | Family with sequence similarity 19 member A4, C-C motif chemokine like
Family with sequence similarity 19 member A4, C-C motif chemokine like is a protein that in humans is encoded by the FAM19A4 gene.
# Function
This gene is a member of the TAFA family which is composed of five highly homologous genes that encode sma... | Family with sequence similarity 19 member A4, C-C motif chemokine like
Family with sequence similarity 19 member A4, C-C motif chemokine like is a protein that in humans is encoded by the FAM19A4 gene.
[1]
# Function
This gene is a member of the TAFA family which is composed of five highly homologous genes that encod... | https://www.wikidoc.org/index.php/Family_with_sequence_similarity_19_member_A4,_C-C_motif_chemokine_like | |
1fef7d80e3d6a3e295ca35a8897e2c4e429ffd40 | wikidoc | Hyperlipidemia statins in children and adolescents with hyperlipidemia | Hyperlipidemia statins in children and adolescents with hyperlipidemia
# Overview
Children and adolescents with high-risk hyperlipidemia require lipid-lowering drug therapy, particularly those with familial hypercholesterolemia, despite compliance with lifestyle recommendations.
# NCEP Recommendations for Statins in ... | Hyperlipidemia statins in children and adolescents with hyperlipidemia
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# Overview
Children and adolescents with high-risk hyperlipidemia require lipid-lowering drug therapy, particularly those with familial hypercholesterolemia, despite compliance with lifestyle reco... | https://www.wikidoc.org/index.php/Hyperlipidemia_statins_in_children_and_adolescents_with_hyperlipidemia | |
6f241787f026ca7a3c251d0d94cae6bc03cdfb53 | wikidoc | Phosphate starvation-response transcription factor gene transcriptions | Phosphate starvation-response transcription factor gene transcriptions
One phosphate starvation-response transcription factor is Pho4.
# Human genes
# Consensus sequences
"The motif is bound by the transcription factor Pho4, class of basic helix-loop-helix DNA binding domain and core recognition sequence (Zhou and ... | Phosphate starvation-response transcription factor gene transcriptions
Associate Editor(s)-in-Chief: Henry A. Hoff
One phosphate starvation-response transcription factor is Pho4.
# Human genes
# Consensus sequences
"The [palindromic E-box motif (CACGTG)] motif is bound by the transcription factor Pho4, [and has the... | https://www.wikidoc.org/index.php/Phosphate_starvation-response_transcription_factor_gene_transcriptions | |
c3db44d5aef0150f0c08735b2da047681a5f3c59 | wikidoc | Special Supplemental Nutrition Program for Women, Infants and Children | Special Supplemental Nutrition Program for Women, Infants and Children
The Special Supplemental Nutrition Program for Women, Infants and Children (known as WIC) is a Federal assistance program of the Food and Nutrition Service (FNS) of the United States Department of Agriculture (USDA) for healthcare and nutrition of l... | Special Supplemental Nutrition Program for Women, Infants and Children
The Special Supplemental Nutrition Program for Women, Infants and Children (known as WIC) is a Federal assistance program of the Food and Nutrition Service (FNS) of the United States Department of Agriculture (USDA) for healthcare and nutrition of ... | https://www.wikidoc.org/index.php/Special_Supplemental_Nutrition_Program_for_Women,_Infants_and_Children | |
d435677a4efe7b4ba3cdd9ed7527199b99d21c37 | wikidoc | Terconazole Vaginal Cream, Vaginal Suppositories (patient information) | Terconazole Vaginal Cream, Vaginal Suppositories (patient information)
# Why is this medication prescribed
Terconazole is used to treat fungal and yeast infections of the vagina.
This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
# How should this medicine be u... | Terconazole Vaginal Cream, Vaginal Suppositories (patient information)
Template:Drug header
# Why is this medication prescribed
Terconazole is used to treat fungal and yeast infections of the vagina.
This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
# How sho... | https://www.wikidoc.org/index.php/Terconazole_(patient_information) | |
b97d69fb673fda2a836ed88477cb18546e347439 | wikidoc | CDC Classification System for HIV Infection in Adults and Adolescents | CDC Classification System for HIV Infection in Adults and Adolescents
# Overview
This classification system is how the United States agency, the Centers for Disease Control and Prevention (CDC) classifies HIV disease and infection. This is to allow the government to handle epidemic statistics and define who receives U... | CDC Classification System for HIV Infection in Adults and Adolescents
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# Overview
This classification system is how the United States agency, the Centers for Disease Control and Prevention (CDC) classifies HIV disease and infection. This is to allow the government to ... | https://www.wikidoc.org/index.php/CDC_Classification_System_for_HIV_Infection_in_Adults_and_Adolescents | |
5308225be43694155df5f4dd63b8eebb38a2e1e1 | wikidoc | Class III A recommendations in guidelines for cardiovascular medicine | Class III A recommendations in guidelines for cardiovascular medicine
# Overview
LOE A is defined as evidence obtained from either multiple populations, multiple randomized clinical trials, or meta-analyses of randomized clinical trials. The total number of class III-LOE A recommendations in guidelines published by Am... | Class III A recommendations in guidelines for cardiovascular medicine
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Aparna Vuppala, M.B.B.S. [2]
# Overview
LOE A is defined as evidence obtained from either multiple populations, multiple randomized clinical tri... | https://www.wikidoc.org/index.php/Class_III_A_recommendations_in_guidelines_for_cardiovascular_medicine | |
47e739d9c0338498528bc85620b9c0be99b4215d | wikidoc | Class III B recommendations in guidelines for cardiovascular medicine | Class III B recommendations in guidelines for cardiovascular medicine
# Overview
LOE B is defined as evidence obtained from either a limited number of populations, a single randomized clinical trial, or meta-analyses of non-randomized studies. The total number of class III-LOE B recommendations in guidelines published... | Class III B recommendations in guidelines for cardiovascular medicine
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Aparna Vuppala, M.B.B.S. [2]
# Overview
LOE B is defined as evidence obtained from either a limited number of populations, a single randomized c... | https://www.wikidoc.org/index.php/Class_III_B_recommendations_in_guidelines_for_cardiovascular_medicine | |
9851747d0eac8f545b0c1d2ef343858501d9f58d | wikidoc | Class III C recommendations in guidelines for cardiovascular medicine | Class III C recommendations in guidelines for cardiovascular medicine
# Overview
LOE C is defined as evidence obtained from either a very limited number of populations, consensus opinion of experts, case studies, or standard of care. The total number of class III-LOE C recommendations in guidelines published by Americ... | Class III C recommendations in guidelines for cardiovascular medicine
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Aparna Vuppala, M.B.B.S. [2]
# Overview
LOE C is defined as evidence obtained from either a very limited number of populations, consensus opinio... | https://www.wikidoc.org/index.php/Class_III_C_recommendations_in_guidelines_for_cardiovascular_medicine | |
aad6e8fe4fbf3336fc1557b8adf19401f22ed850 | wikidoc | Elvitegravir cobicistat emtricitabine tenofovir (patient information) | Elvitegravir cobicistat emtricitabine tenofovir (patient information)
# Patient Information
See FDA-Approved Patient Labeling (Patient Information)
A statement to patients and healthcare providers is included on the product's bottle label: ALERT: Find out about medicines that should NOT be taken with STRIBILD.
Patient... | Elvitegravir cobicistat emtricitabine tenofovir (patient information)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
# Patient Information
See FDA-Approved Patient Labeling (Patient Information)
A statement to patients and healthcare providers is included... | https://www.wikidoc.org/index.php/Elvitegravir_cobicistat_emtricitabine_tenofovir_(patient_information) | |
3f276c796ed273d81b4b74afd7f4d59faade6ed2 | wikidoc | Elvitegravir cobicistat emtricitabine tenofovir clinical pharmacology | Elvitegravir cobicistat emtricitabine tenofovir clinical pharmacology
# Clinical Pharmacology
## Pharmacodynamics
Effects on Electrocardiogram
Thorough QT studies have been conducted for elvitegravir and cobicistat. The effect of the other two components, tenofovir and emtricitabine, or the combination regimen STRIBI... | Elvitegravir cobicistat emtricitabine tenofovir clinical pharmacology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
# Clinical Pharmacology
## Pharmacodynamics
Effects on Electrocardiogram
Thorough QT studies have been conducted for elvitegravir and cob... | https://www.wikidoc.org/index.php/Elvitegravir_cobicistat_emtricitabine_tenofovir_clinical_pharmacology | |
baca08d3c7372a49ba9be3cce75eec4645badabd | wikidoc | Emtricitabine and tenofovir disoproxil fumarate (patient information) | Emtricitabine and tenofovir disoproxil fumarate (patient information)
# IMPORTANT WARNING
Emtricitabine and tenofovir may cause life-threatening damage to the liver and a potentially life-threatening condition called lactic acidosis (buildup of lactic acid in the blood) when used alone or in combination with other med... | Emtricitabine and tenofovir disoproxil fumarate (patient information)
Template:Drug header
# IMPORTANT WARNING
Emtricitabine and tenofovir may cause life-threatening damage to the liver and a potentially life-threatening condition called lactic acidosis (buildup of lactic acid in the blood) when used alone or in comb... | https://www.wikidoc.org/index.php/Emtricitabine_and_tenofovir_disoproxil_fumarate_(patient_information) | |
0f98de4bbf21c24ccb7bdbc8c5d9391ba10c48a7 | wikidoc | Group B streptococcal septicemia of the newborn (patient information) | Group B streptococcal septicemia of the newborn (patient information)
# Overview
Group B streptococcal septicemia is a severe bacterial infection that affects newborn infants.
# What are the symptoms of Group B streptococcal septicemia of the newborn?
- Anxious or stressed appearance
- Blue appearance (cyanosis)
- Br... | Group B streptococcal septicemia of the newborn (patient information)
Editor-in-Chief: C. Michael Gibson, M.S.,M.D. [1] Phone:617-632-7753; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S.
# Overview
Group B streptococcal septicemia is a severe bacterial infection that affects newborn infants.
# What a... | https://www.wikidoc.org/index.php/Group_B_streptococcal_septicemia_of_the_newborn_(patient_information) | |
61cc541c0a5896a1acb9a05bc2e7820bc66fba6e | wikidoc | Measuring Fractional Flow Reserve During PCI Improves 1-Year Outcomes | Measuring Fractional Flow Reserve During PCI Improves 1-Year Outcomes
January 26, 2009 By Michael W Tempelhof, MD
Percutaneous coronary intervention (PCI) for treatment of NSTEMI and/or STEMI from ischemia has been associated with improvements in short-term and long-term clinical outcomes. However, in ischemic patient... | Measuring Fractional Flow Reserve During PCI Improves 1-Year Outcomes
January 26, 2009 By Michael W Tempelhof, MD [1]
Percutaneous coronary intervention (PCI) for treatment of NSTEMI and/or STEMI from ischemia has been associated with improvements in short-term and long-term clinical outcomes. However, in ischemic pat... | https://www.wikidoc.org/index.php/Measuring_Fractional_Flow_Reserve_During_PCI_Improves_1-Year_Outcomes | |
25775b538522b2763b2a64e657277b910de92f96 | wikidoc | NICE guidelines for the management of patients with stable chest pain | NICE guidelines for the management of patients with stable chest pain
# Overview
In the 2016 update of the stable chest pain guideline, National Institute for Health and Clinical Excellence (NICE) has dramatically changed its approach to new-onset stable chest pain aiming to find a more cost-effective strategy includi... | NICE guidelines for the management of patients with stable chest pain
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief:Sara Zand, M.D.[2] Cafer Zorkun, M.D., Ph.D. [3]; Priyamvada Singh, M.B.B.S. [4]
# Overview
In the 2016 update of the stable chest pain guideline, National Institute f... | https://www.wikidoc.org/index.php/NICE_guidelines_for_the_management_of_patients_with_stable_chest_pain | |
db37469b79303830192f7a195f73eac47b118ee5 | wikidoc | Reserpine, hydralazine, and hydrochlorothiazide (patient information) | Reserpine, hydralazine, and hydrochlorothiazide (patient information)
# IMPORTANT WARNING:
Reserpine, hydralazine, and hydrochlorothiazide is no longer available in the U.S. If you are currently taking reserpine, hydralazine, and hydrochlorothiazide, you should call your doctor to discuss switching to another treatmen... | Reserpine, hydralazine, and hydrochlorothiazide (patient information)
Template:Drug header
# IMPORTANT WARNING:
Reserpine, hydralazine, and hydrochlorothiazide is no longer available in the U.S. If you are currently taking reserpine, hydralazine, and hydrochlorothiazide, you should call your doctor to discuss switchi... | https://www.wikidoc.org/index.php/Reserpine,_hydralazine,_and_hydrochlorothiazide | |
bd39c5059e57509a46d4a06e9469ff924bc1782c | wikidoc | Stents: Johnson & Johnson Reports Significant Decrease in Stent Sales | Stents: Johnson & Johnson Reports Significant Decrease in Stent Sales
July 19, 2007 by Scott P. Williams
Although healthcare conglomerate Johnson & Johnson reported a 9% increase in its second quarter profits compared to one year ago, the company saw a 20% decrease in sales within its recently troubled stent unit.
On a... | Stents: Johnson & Johnson Reports Significant Decrease in Stent Sales
July 19, 2007 by Scott P. Williams
[1]
Although healthcare conglomerate Johnson & Johnson reported a 9% increase in its second quarter profits compared to one year ago, the company saw a 20% decrease in sales within its recently troubled stent unit.... | https://www.wikidoc.org/index.php/Stents:_Johnson_%26_Johnson_Reports_Significant_Decrease_in_Stent_Sales | |
ab1e21637494666a8d964532c6083ac7b75a4303 | wikidoc | Systemic EBV positive T-cell lymphoproliferative disease of childhood | Systemic EBV positive T-cell lymphoproliferative disease of childhood
Synonyms and keywords:
# Overview
# Historical Perspective
# Classification
# Pathophysiology
# Causes
# Differentiating Systemic EBV positive T-cell lymphoproliferative disease of childhood from other Diseases
# Epidemiology and Demographics
... | Systemic EBV positive T-cell lymphoproliferative disease of childhood
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alberto Plate [2]
Synonyms and keywords:
# Overview
# Historical Perspective
# Classification
# Pathophysiology
# Causes
# Differentiating Systemic EBV positive... | https://www.wikidoc.org/index.php/Systemic_EBV_positive_T-cell_lymphoproliferative_disease_of_childhood | |
8a4ee6c3523220e721fddf3beacf0b7d25a67eed | wikidoc | United States Senate Committee on Agriculture, Nutrition and Forestry | United States Senate Committee on Agriculture, Nutrition and Forestry
The Committee of Agriculture, Nutrition and Forestry is a committee of the United States Senate empowered with legislative oversight of all matters relating to the nation's agriculture industry, farming programs, forestry and logging, and legislation... | United States Senate Committee on Agriculture, Nutrition and Forestry
The Committee of Agriculture, Nutrition and Forestry is a committee of the United States Senate empowered with legislative oversight of all matters relating to the nation's agriculture industry, farming programs, forestry and logging, and legislatio... | https://www.wikidoc.org/index.php/United_States_Senate_Committee_on_Agriculture,_Nutrition_and_Forestry | |
a4653f566ab17903894936526358b1f4cb32a4a7 | wikidoc | ACC/AHA guideline on the secondary prevention of hypercholestrolemia | ACC/AHA guideline on the secondary prevention of hypercholestrolemia
# 2013 ACC AHA guideline on the treatment of blood cholesterol secondary prevention
# Secondary Prevention
# Initiating and Management of Statin Therapy in Individuals with Clinical ASCVD
Clinical ASCVD is defined as acute coronary syndromes or his... | ACC/AHA guideline on the secondary prevention of hypercholestrolemia
Template:Hypercholesterolemia
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
## 2013 ACC AHA guideline on the treatment of blood cholesterol secondary prevention
## Secondary Prevention
## Initiating and Management of Statin Therapy in Individ... | https://www.wikidoc.org/index.php/ACC/AHA_guideline_on_the_secondary_prevention_of_hypercholestrolemia | |
a0ecff8a08f79aa62e65dd76ecced024f0203046 | wikidoc | Clinical event adjudication: Heart failure requiring hospitalization | Clinical event adjudication: Heart failure requiring hospitalization
For the list of clinical event adjudication definitions, click here
This chapter presents heart failure requiring hospitalization definitions used in the Clinical Event Committee adjudication processes. These definitions are current as of 3/26/10.
# ... | Clinical event adjudication: Heart failure requiring hospitalization
For the list of clinical event adjudication definitions, click here
Editors-in-Chief: C. Michael Gibson, M.S., M.D. [1]
This chapter presents heart failure requiring hospitalization definitions used in the Clinical Event Committee adjudication proces... | https://www.wikidoc.org/index.php/Clinical_event_adjudication:_Heart_failure_requiring_hospitalization | |
d3763783ce52c076391bd7ad559f65699cde99ab | wikidoc | Differentiating drug-induced lupus erythematosus from other diseases | Differentiating drug-induced lupus erythematosus from other diseases
# Overview
# Differentiating Drug-Induced Lupus Erythematosus from other Diseases
As a reminder, rheumatologic conditions tend to declare themselves over time, as opposed to immediately displaying all the classic clinical manifestations of the disea... | Differentiating drug-induced lupus erythematosus from other diseases
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# Overview
# Differentiating Drug-Induced Lupus Erythematosus from other Diseases
As a reminder, rheumatologic conditions tend to declare themselves over time, as opposed to immediately displaying ... | https://www.wikidoc.org/index.php/Differentiating_drug-induced_lupus_erythematosus_from_other_diseases | |
f6fe323be413a69f9e661ee9bf628e976193d2fb | wikidoc | NICE guidelines for the management of patients with acute chest pain | NICE guidelines for the management of patients with acute chest pain
# Overview
In the 2016 update of the stable chest pain guideline, National Institute for Health and Clinical Excellence (NICE) has dramatically changed its approach to new-onset stable chest pain aiming to find a more cost-effective strategy includin... | NICE guidelines for the management of patients with acute chest pain
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Sara Zand, M.D.[2] Cafer Zorkun, M.D., Ph.D. [3]; Priyamvada Singh, M.B.B.S. [4]
# Overview
In the 2016 update of the stable chest pain guideline, National Institute f... | https://www.wikidoc.org/index.php/NICE_guidelines_for_the_management_of_patients_with_acute_chest_pain | |
72f2aba565be6e90d34cc47a7a273387dd41d23f | wikidoc | Neomycin, polymyxin, and bacitracin ophthalmic (patient information) | Neomycin, polymyxin, and bacitracin ophthalmic (patient information)
# Why is this medication prescribed
Neomycin, polymyxin, and bacitracin combination is used to treat eye and eyelid infections. Neomycin, polymyxin, and bacitracin are in a class of medications called antibiotics. Neomycin, polymyxin, and bacitracin ... | Neomycin, polymyxin, and bacitracin ophthalmic (patient information)
Template:Drug header
# Why is this medication prescribed
Neomycin, polymyxin, and bacitracin combination is used to treat eye and eyelid infections. Neomycin, polymyxin, and bacitracin are in a class of medications called antibiotics. Neomycin, poly... | https://www.wikidoc.org/index.php/Neomycin,_polymyxin,_and_bacitracin_ophthalmic | |
2b6c777bf9621baef201dfcd65de7a1e60c19e8c | wikidoc | Peroxisome proliferator hormone response element gene transcriptions | Peroxisome proliferator hormone response element gene transcriptions
"After activation by ligands, PPARs/RXRs heterodimers bind to PPRE consensus sequence (AGGTCANAGGTCA) in the promoter of their target genes."
Peroxisome proliferator hormone response elements (PPREs) consensus sequences are AGGGGA and TCCCCT.
# Human... | Peroxisome proliferator hormone response element gene transcriptions
Associate Editor(s)-in-Chief: Henry A. Hoff
"After activation by ligands, PPARs/RXRs heterodimers bind to PPRE consensus sequence (AGGTCANAGGTCA) in the promoter of their target genes."[1]
Peroxisome proliferator hormone response elements (PPREs) co... | https://www.wikidoc.org/index.php/Peroxisome_proliferator_hormone_response_element_gene_transcriptions | |
736664e10bffc9b58b2874abde1746a4c27b1bf0 | wikidoc | Sandbox:Otitis externa natural history, complications, and prognosis | Sandbox:Otitis externa natural history, complications, and prognosis
# Overview
The prognosis of otitis externa varies based on the presence of complications from the spread of the infectious pathogen. Without treatment, the prognosis of acute otitis externa is usually good and it is self-limited. It usually develops ... | Sandbox:Otitis externa natural history, complications, and prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.
# Overview
The prognosis of otitis externa varies based on the presence of complications from the spread of the infectious pathogen. Without ... | https://www.wikidoc.org/index.php/Sandbox:Otitis_externa_natural_history,_complications,_and_prognosis | |
3233ecd725d9a88455b36ef167b99deacb86b4a7 | wikidoc | Tetradecanoylphorbol-13-acetate response element gene transcriptions | Tetradecanoylphorbol-13-acetate response element gene transcriptions
Activator protein 1 (AP-1) was first discovered as a 12-O-Tetradecanoylphorbol-13-acetate (TPA)-activated transcription factor that bound to a cis-regulatory element of the human metallothionein IIa (hMTIIa) promoter and SV40.
# Consensus sequences
T... | Tetradecanoylphorbol-13-acetate response element gene transcriptions
Associate Editor(s)-in-Chief: Henry A. Hoff
Activator protein 1 (AP-1) was first discovered as a 12-O-Tetradecanoylphorbol-13-acetate (TPA)-activated transcription factor that bound to a cis-regulatory element of the human metallothionein IIa (hMTII... | https://www.wikidoc.org/index.php/Tetradecanoylphorbol-13-acetate_response_element_gene_transcriptions | |
3350fc7e12eda8f8f0c1c9703843615df1a56b59 | wikidoc | Valproic acid capsule delayed release patient counseling information | Valproic acid capsule delayed release patient counseling information
# Patient Counseling Information
See FDA-Approved patient labeling (Medication Guide)
### 17.1 Hepatotoxicity
Patients and guardians should be warned that nausea, vomiting, abdominal pain, anorexia, diarrhea, asthenia, and/or jaundice can be symptom... | Valproic acid capsule delayed release patient counseling information
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# Patient Counseling Information
See FDA-Approved patient labeling (Medication Guide)
### 17.1 Hepatotoxicity
Patients and guardians should be warned that nausea, vomiting, abdominal pain, anorexia... | https://www.wikidoc.org/index.php/Valproic_acid_capsule_delayed_release_patient_counseling_information | |
bed932eba6026759024fc3f64502e66e2e7861e5 | wikidoc | Aboriginal Protection and restriction of the sale of opium act 1897 | Aboriginal Protection and restriction of the sale of opium act 1897
The Aboriginal Protection and Restrictions of the Sale of Opium Act 1897 was an Act of the Parliament of Queensland.
As a result of dispersal, malnutrition, opium and diseases, it was widely believed in Queensland that Aborigines were members of a 'dyi... | Aboriginal Protection and restriction of the sale of opium act 1897
The Aboriginal Protection and Restrictions of the Sale of Opium Act 1897 was an Act of the Parliament of Queensland.
As a result of dispersal, malnutrition, opium and diseases, it was widely believed in Queensland that Aborigines were members of a 'dy... | https://www.wikidoc.org/index.php/Aboriginal_Protection_and_restriction_of_the_sale_of_opium_act_1897 | |
951f6ef7a9457e7d8ab2690b26cc94f158fdd90d | wikidoc | Differentiating Secondary adrenal insufficiency from other diseases | Differentiating Secondary adrenal insufficiency from other diseases
# Overview
Secondary adrenal insufficiency must be differentiated from primary adrenal insufficiency, acute adrenal insufficiency/adrenal crisis, adrenal hemorrhage, congenital adrenal hyperplasia and salt losing nephropathy based on clinical features... | Differentiating Secondary adrenal insufficiency from other diseases
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
# Overview
Secondary adrenal insufficiency must be differentiated from primary adrenal insufficiency, acute adrenal insufficiency/adrenal crisis,... | https://www.wikidoc.org/index.php/Adrenal_crisis | |
58e910da65215b86a204aa484e521b941fadb605 | wikidoc | Class III recommendations in guidelines for cardiovascular medicine | Class III recommendations in guidelines for cardiovascular medicine
# Overview
Class III recommendations are defined as conditions for which there is evidence and/or general agreement that the procedure or treatment is not useful/effective and in some cases may be harmful. Class III guidelines may be further classifie... | Class III recommendations in guidelines for cardiovascular medicine
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Aparna Vuppala, M.B.B.S. [2]
# Overview
Class III recommendations are defined as conditions for which there is evidence and/or general agreement t... | https://www.wikidoc.org/index.php/CV_guidelines_class_III_recommendations | |
09b7162cdf3d9f6ee5c69f477ab41cb84e2abe8b | wikidoc | Differentiating Anti-NMDA receptor encephalitis from other diseases | Differentiating Anti-NMDA receptor encephalitis from other diseases
# Overview
In the differential diagnosis of anti-NMDA encephalitis, other autoimmune encephalitides with specific antibody associations should be considered, including those associated with antibodies against AMPA receptors, GABA-B receptors, LGI1, Ca... | Differentiating Anti-NMDA receptor encephalitis from other diseases
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ;AE Dheeraj Makkar, M.D.[2]
# Overview
In the differential diagnosis of anti-NMDA encephalitis, other autoimmune encephalitides with specific antibody associations should be considered, including tho... | https://www.wikidoc.org/index.php/Differentiating_Anti-NMDA_receptor_encephalitis_from_other_diseases | |
d197d8ce07a892e296d46863d7c971564afa681f | wikidoc | Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage | Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
# 2012 AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
## Risk Factors for and Prevention of aSAH: Recommendations
## Natural History and Outcome of aSAH: Recommendations
## Clinical Manifestations and Diagnosis of aSAH:... | Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Sara Mehrsefat, M.D. [2]
# 2012 AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage[1]
## Risk Factors for and Prevention of aSAH: Recommendati... | https://www.wikidoc.org/index.php/Guidelines_for_the_Management_of_Aneurysmal_Subarachnoid_Hemorrhage | |
382ad45e41da372b5bccd5eb3f5e7190dca3b6ed | wikidoc | Hepatology, Gallbladder, and Biliary Tract Diseases Project Outline | Hepatology, Gallbladder, and Biliary Tract Diseases Project Outline
# Overview
- Below is a list of topics for the Hepatology, Gallbladder, and Biliary Tract Diseases Project.
- The list includes only adult diseases. Pediatric diseases are covered in the Pediatrics Textbook.
- The list does not include oncologic disea... | Hepatology, Gallbladder, and Biliary Tract Diseases Project Outline
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Serge Korjian M.D.
# Overview
- Below is a list of topics for the Hepatology, Gallbladder, and Biliary Tract Diseases Project.
- The list includes ... | https://www.wikidoc.org/index.php/Hepatology,_Gallbladder,_and_Biliary_Tract_Diseases_Project_Outline | |
9f151e94c5d094efd070dd32bd8a7f865284fe0a | wikidoc | Major or mild neurocognitive disorder due to traumatic brain injury | Major or mild neurocognitive disorder due to traumatic brain injury
# Overview
# Major or Mild Neurocognitive Disorder Due to Traumatic Brain Injury
## DSM-V Diagnostic Criteria for Major or Mild Neurocognitive Disorder Due To Traumatic Brain Injury
- A. The criteria are met for major or mild neurocognitive disorder... | Major or mild neurocognitive disorder due to traumatic brain injury
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]
# Overview
# Major or Mild Neurocognitive Disorder Due to Traumatic Brain Injury
## DSM-V Diagnostic Criteria for Major or Mild Neurocognitive ... | https://www.wikidoc.org/index.php/Major_or_Mild_Neurocognitive_Disorder_Due_to_Traumatic_Brain_Injury | |
bc05fde19e33cacfae771f436ce0ffdccc06cbe1 | wikidoc | Methylprednisolone Sodium Succinate Injection (patient information) | Methylprednisolone Sodium Succinate Injection (patient information)
# About your treatment
Your doctor has ordered methylprednisolone, a corticosteroid, to relieve inflammation (swelling, heat, redness, and pain). The drug will be added to an intravenous fluid that will drip through a needle or catheter placed in your... | Methylprednisolone Sodium Succinate Injection (patient information)
Template:Drug header
# About your treatment
Your doctor has ordered methylprednisolone, a corticosteroid, to relieve inflammation (swelling, heat, redness, and pain). The drug will be added to an intravenous fluid that will drip through a needle or c... | https://www.wikidoc.org/index.php/Methylprednisolone_Sodium_Succinate_Injection | |
3810aadeaa0a65de26be38c58f66a1d4d773e403 | wikidoc | Peripheral angioplasty discharge instructions (patient information) | Peripheral angioplasty discharge instructions (patient information)
# Overview
You had angioplasty (ballooning) of a peripheral artery, a blood vessel that supplies blood to your legs or arms. You may have also had a stent placed. These procedures were done to open a narrowed or blocked peripheral artery.
Your doctor ... | Peripheral angioplasty discharge instructions (patient information)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Mohammed A. Sbeih, M.D.[2]
# Overview
You had angioplasty (ballooning) of a peripheral artery, a blood vessel that supplies blood to your legs or arms. You may have also ... | https://www.wikidoc.org/index.php/Peripheral_angioplasty_discharge_instructions | |
484ded17ed664dccc2ecde2e54a1f5c832bd1601 | wikidoc | Sandbox: Otitis media natural history, complications, and prognosis | Sandbox: Otitis media natural history, complications, and prognosis
# Overview
The prognosis of otitis media is usually good with or without treatment, but varies based on the classification. Acute otitis media is self-limited and usually resolves itself within 14 days, and otitis media with effusion will typically re... | Sandbox: Otitis media natural history, complications, and prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.
# Overview
The prognosis of otitis media is usually good with or without treatment, but varies based on the classification. Acute otitis medi... | https://www.wikidoc.org/index.php/Sandbox:_Otitis_media_natural_history,_complications,_and_prognosis | |
bb37c5b9b0175d5b18a17e587994650e0b95a00f | wikidoc | Squamous cell carcinoma natural history complications and prognosis | Squamous cell carcinoma natural history complications and prognosis
# Natural History
Once Squamous cell carcinoma (SCC) develops on the skin it grows slowly. If neglected and once it reaches the size of 2 cm and more it is three times more likely to spread to other areas than the smaller lesions. Usual size ranges fr... | Squamous cell carcinoma natural history complications and prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S.[2], Raviteja Guddeti, M.B.B.S. [3]
# Natural History
Once Squamous cell carcinoma (SCC) develops on the skin it grows slowly. If negle... | https://www.wikidoc.org/index.php/Squamous_cell_carcinoma_natural_history_complications_and_prognosis | |
e249d25fffdc0e32371718247c70eb321fabc843 | wikidoc | The Physical Examination in Cardiovascular Disease: The Extremities | The Physical Examination in Cardiovascular Disease: The Extremities
# Acrocyanosis
Acrocyanosis is constant, painless symmetric cyanosis of the hands which is due to vasospasm of the small vessels of the skin. It can occur on the feet, although less common
# Arterial Bruit
# Clubbing
Clubbing refers to a thickening ... | The Physical Examination in Cardiovascular Disease: The Extremities
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# Acrocyanosis
Acrocyanosis is constant, painless symmetric cyanosis of the hands which is due to vasospasm of the small vessels of the skin. It can occur on the feet, although less common
# Arteria... | https://www.wikidoc.org/index.php/The_Physical_Examination_in_Cardiovascular_Disease:_The_Extremities | |
b9d0faf6088f4c3663e8b42f1dae5776f1b6cc61 | wikidoc | Transjugular intrahepatic portosystemic shunt (patient information) | Transjugular intrahepatic portosystemic shunt (patient information)
For the WikiDoc page for this topic, click here
# Description
The transjugular intrahepatic portosystemic shunt (TIPS) is a radiologic procedure in which a stent (a tubular device) like a tunnel is placed in the middle of the liver to reroute the bloo... | Transjugular intrahepatic portosystemic shunt (patient information)
For the WikiDoc page for this topic, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Umar Ahmad, M.D.[2]
# Description
The transjugular intrahepatic portosystemic shunt (TIPS) is a radiologic procedure in... | https://www.wikidoc.org/index.php/Transjugular_intrahepatic_portosystemic_shunt_(patient_information) | |
584f0ed660e3c9d8d0cc94911deb31a76f64c743 | wikidoc | United states preventive services task force recommendations scheme | United states preventive services task force recommendations scheme
# USPSTF Grade Definitions
### Grade: A
- The USPSTF recommends the service.
- There is high certainty that the net benefit is substantial.
### Grade: B
- The USPSTF recommends the service.
- There is high certainty that the net benefit is moderate... | United states preventive services task force recommendations scheme
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]
# USPSTF Grade Definitions [3]
### Grade: A
- The USPSTF recommends the service.
- There is high certainty that the net benefit is... | https://www.wikidoc.org/index.php/USPSTF | |
0f602ab8cb23408d4b18dc56f2a8c5c724a0a0c9 | wikidoc | ACC AHA guideline on the primary prevention of hypercholestrolemia | ACC AHA guideline on the primary prevention of hypercholestrolemia
# 2018 AHA ACC Guideline on the Management of Blood Cholesterol. Primary Prevention
## Primary Prevention Adults 40 to 75 Years of Age With LDL-C Levels 70 to 189 mg/dL (1.7 to 4.8 mmol/L)
## Monitoring in Response to LDL-C–Lowering Therapy
## Prima... | ACC AHA guideline on the primary prevention of hypercholestrolemia
Template:Hypercholesterolemia
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jair Basantes de la Calle, M.D.
# 2018 AHA ACC Guideline on the Management of Blood Cholesterol. Primary Prevention
## Primary Prevention... | https://www.wikidoc.org/index.php/ACC_AHA_guideline_on_the_primary_prevention | |
11d2b4c79c726e02bc2bdfd4728855e40fe18135 | wikidoc | Differentiating COVID-associated heart failure from other Diseases | Differentiating COVID-associated heart failure from other Diseases
# Overview
COVID-associated heart failure must be differentiated from other causes of dyspnea and/or hypoxia, including pneumonia, acute respiratory distress syndrome, myocarditis, and pulmonary embolism.
# Differential Diagnosis
COVID-associated hear... | Differentiating COVID-associated heart failure from other Diseases
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mitra Chitsazan, M.D.[2] Mandana Chitsazan, M.D. [3]
# Overview
COVID-associated heart failure must be differentiated from other causes of dyspnea and/or hypoxia, inclu... | https://www.wikidoc.org/index.php/Differentiating_COVID-associated_heart_failure_from_other_Diseases | |
9f9c8f68649f5413b36b68c8243c746980af616f | wikidoc | Elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide | Elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide
# Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of hea... | Elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Allison Tu [2]
# Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed ... | https://www.wikidoc.org/index.php/Elvitegravir,_cobicistat,_emtricitabine,_and_tenofovir_alafenamide | |
8f4f781e3be358f2e8db2960dab7d0f04a564df0 | wikidoc | Estrogen and Progestin (Oral Contraceptives) (patient information) | Estrogen and Progestin (Oral Contraceptives) (patient information)
# IMPORTANT WARNING
Cigarette smoking increases the risk of serious side effects from oral contraceptives, including heart attacks, blood clots, and strokes. This risk is higher for women over 35 years old and heavy smokers (15 or more cigarettes per d... | Estrogen and Progestin (Oral Contraceptives) (patient information)
Template:Drug header
# IMPORTANT WARNING
Cigarette smoking increases the risk of serious side effects from oral contraceptives, including heart attacks, blood clots, and strokes. This risk is higher for women over 35 years old and heavy smokers (15 or... | https://www.wikidoc.org/index.php/Estrogen_and_Progestin_(Oral_Contraceptives) | |
c34791e9eac81f31e8de1f9f4400c7ef313dad7c | wikidoc | International Society on Thrombosis and Haemostasis bleeding scale | International Society on Thrombosis and Haemostasis bleeding scale
# Overview
The International Society on Thrombosis and Haemostasis (ISTH)/Scientific and Standardization Committee (SSC) definitions and bleeding assessment tool are useful for standardizing the reporting of bleeding symptoms.
# ISTH Definitions of Bl... | International Society on Thrombosis and Haemostasis bleeding scale
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# Overview
The International Society on Thrombosis and Haemostasis (ISTH)/Scientific and Standardization Committee (SSC) definitions and bleeding assessment tool are useful for standardizing the repor... | https://www.wikidoc.org/index.php/International_Society_on_Thrombosis_and_Haemostasis_bleeding_scale | |
edf20e13115007e5096a017658c16044fc8c152f | wikidoc | National Organization of Circumcision Information Resource Centers | National Organization of Circumcision Information Resource Centers
# Overview
The National Organization of Circumcision Information Resource Centers (NOCIRC) is a non-profit organization headquartered in the United States, with some centers in other countries. Its goal is to secure "the birthright of male, female, an... | National Organization of Circumcision Information Resource Centers
# Overview
The National Organization of Circumcision Information Resource Centers (NOCIRC) is a non-profit organization headquartered in the United States, with some centers in other countries. Its goal is to secure "the birthright of male, female, an... | https://www.wikidoc.org/index.php/NOCIRC | |
23ff99cbb7ba2a93030d7cd0d1f62f72275705a1 | wikidoc | Osteochondrodysplatic dwarfism -- deafness -- retinitis pigmentosa | Osteochondrodysplatic dwarfism -- deafness -- retinitis pigmentosa
# Overview
Osteochondrodysplatic dwarfism -- deafness -- retinitis pigmentosa is an autosomal dominant disease characterized by dwarfism and musculoskeletal problems along with deafness and eye problems.
# Pathophysiology
The disease seems to have a d... | Osteochondrodysplatic dwarfism -- deafness -- retinitis pigmentosa
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
# Overview
Osteochondrodysplatic dwarfism -- deafness -- retinitis pigmentosa is an autosomal dominant disease characterized by dwarfism ... | https://www.wikidoc.org/index.php/Osteochondrodysplatic_dwarfism_--_deafness_--_retinitis_pigmentosa | |
7b943cbdc74412be4d0f5c218b1fbfa9aabaa936 | wikidoc | Palliative treatment in dextro-transposition of the great arteries | Palliative treatment in dextro-transposition of the great arteries
# Overview
# Palliative treatment
Critically ill newborns benefit from the infusion of Prostaglanding E1, which is used to prevent closure of the PDA (additional shunt) through which the systemic circulation is provided with a higher level of oxygen.
... | Palliative treatment in dextro-transposition of the great arteries
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Keri Shafer, M.D. [4]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [5]
# Overview
# Palliative tre... | https://www.wikidoc.org/index.php/Palliative_treatment_in_dextro-transposition_of_the_great_arteries | |
e022a766e1a0c60f1bad54b773cfb90cde0cf080 | wikidoc | University College of Medicine and Dentistry, University of Lahore | University College of Medicine and Dentistry, University of Lahore
University College of Medicine and Dentistry, University of Lahore is one of the most prestigious medical schools in Pakistan. It is often abbreviated as UCM, UOL.
# History
# Campus and departments
The university has following departments:
Basic scie... | University College of Medicine and Dentistry, University of Lahore
Template:Infobox University
University College of Medicine and Dentistry, University of Lahore is one of the most prestigious medical schools in Pakistan. It is often abbreviated as UCM, UOL.
# History
# Campus and departments
The university has foll... | https://www.wikidoc.org/index.php/University_College_of_Medicine_and_Dentistry,_University_of_Lahore | |
80d566adb8c15241081eb3f7e0168c7611fb2c33 | wikidoc | Alternative therapies for developmental and learning disabilities | Alternative therapies for developmental and learning disabilities
Alternative therapies for developmental and learning disabilities include a range of practices used in the treatment of dyslexia, ADHD, Asperger syndrome, autism, Down syndrome and other developmental and learning disabilities. Treatments include changes... | Alternative therapies for developmental and learning disabilities
Alternative therapies for developmental and learning disabilities include a range of practices used in the treatment of dyslexia, ADHD, Asperger syndrome, autism, Down syndrome and other developmental and learning disabilities. Treatments include change... | https://www.wikidoc.org/index.php/Alternative_therapies_for_developmental_and_learning_disabilities | |
fe908757ef198863b7cc6d9aa2b9c2b4b5cf20d9 | wikidoc | Bictegravir sodium, emtricitabine, tenofovir alafenamide fumarate | Bictegravir sodium, emtricitabine, tenofovir alafenamide fumarate
# Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of heal... | Bictegravir sodium, emtricitabine, tenofovir alafenamide fumarate
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zach Leibowitz [2]
# Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licens... | https://www.wikidoc.org/index.php/Bictegravir_sodium,_emtricitabine,_tenofovir_alafenamide_fumarate | |
88c3e4a2ab1f7f540fa24ba4a3fe9f955c4b3c15 | wikidoc | Coronary angioplasty discharge instructions (patient information) | Coronary angioplasty discharge instructions (patient information)
# Overview
If you have coronary artery disease, the arteries in your heart are narrowed or blocked by a sticky material called plaque. Angioplasty is a procedure to restore blood flow through the artery. The doctor threads a thin tube through a blood ve... | Coronary angioplasty discharge instructions (patient information)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Mohammed A. Sbeih, M.D. [2]
# Overview
If you have coronary artery disease, the arteries in your heart are narrowed or blocked by a sticky material called plaque. Angioplas... | https://www.wikidoc.org/index.php/Coronary_angioplasty_discharge_instructions_(patient_information) | |
36a5b7d14970d556f0de9875ffb38d46ad3940ea | wikidoc | Dihydroergotamine Injection and Nasal Spray (patient information) | Dihydroergotamine Injection and Nasal Spray (patient information)
# IMPORTANT WARNING
Do not take dihydroergotamine if you are taking any of the following medications: antifungals such as itraconazole (Sporanox) and ketoconazole (Nizoral); HIV protease inhibitors such as indinavir (Crixivan), nelfinavir (Viracept), an... | Dihydroergotamine Injection and Nasal Spray (patient information)
Template:Drug header
# IMPORTANT WARNING
Do not take dihydroergotamine if you are taking any of the following medications: antifungals such as itraconazole (Sporanox) and ketoconazole (Nizoral); HIV protease inhibitors such as indinavir (Crixivan), nel... | https://www.wikidoc.org/index.php/Dihydroergotamine_Injection_and_Nasal_Spray | |
938fb71642185fce588d5a5b4cc57a4eeec363f4 | wikidoc | Ebstein's anomaly of the tricuspid valve associated abnormalities | Ebstein's anomaly of the tricuspid valve associated abnormalities
# Associated Abnormalities
While Ebstein's anomaly is defined as the congenital displacement of the tricuspid valve towards the apex of the right ventricle, it is often associated with other abnormalities.
## Anatomy
Typically, there are anatomic abnor... | Ebstein's anomaly of the tricuspid valve associated abnormalities
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] and Claudia P. Hochberg, M.D. [2]
Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [3]
# Associated Abnormalities
While Ebstein's anomaly is defined as the congenital displacement of the tricuspid ... | https://www.wikidoc.org/index.php/Ebstein%27s_anomaly_of_the_tricuspid_valve_associated_abnormalities | |
b24e4ab12e0d84cf86855bf6e11dae4290d9cebd | wikidoc | Elvitegravir cobicistat emtricitabine tenofovir drug interactions | Elvitegravir cobicistat emtricitabine tenofovir drug interactions
# Drug Interactions
## Other Antiretroviral Medications
STRIBILD is a complete regimen for the treatment of HIV-1 infection; therefore, STRIBILD should not be administered with other antiretroviral medications for treatment of HIV-1 infection. Complete... | Elvitegravir cobicistat emtricitabine tenofovir drug interactions
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
# Drug Interactions
## Other Antiretroviral Medications
STRIBILD is a complete regimen for the treatment of HIV-1 infection; therefore, STRIB... | https://www.wikidoc.org/index.php/Elvitegravir_cobicistat_emtricitabine_tenofovir_drug_interactions | |
64a53ce943e76bc313c684ad99353564f622a461 | wikidoc | Endoplasmic reticulum stress response element gene transcriptions | Endoplasmic reticulum stress response element gene transcriptions
# Human genes
# Consensus sequences
"The released aminoterminal of ATF6 (ATF6-N) then migrates to the nucleus and binds to the ER stress response element (ERSE) containing the consensus sequence CCAAT-N9-CCACG to activate genes encoding ER chaperones, ... | Endoplasmic reticulum stress response element gene transcriptions
Associate Editor(s)-in-Chief: Henry A. Hoff
# Human genes
# Consensus sequences
"The released aminoterminal of ATF6 (ATF6-N) then migrates to the nucleus and binds to the ER stress response element (ERSE) containing the consensus sequence CCAAT-N9-CC... | https://www.wikidoc.org/index.php/Endoplasmic_reticulum_stress_response_element_gene_transcriptions | |
c53bfc03bea4b46765d3d65abd8e2254c3b34b35 | wikidoc | Haemophilus influenzae Type b (Hib) Vaccine (patient information) | Haemophilus influenzae Type b (Hib) Vaccine (patient information)
For the WikiDoc page for Haemophilus influenzae infection, click here
For patient information about Haemophilus influenzae infection, click here
# What is Hib disease
Haemophilus influenzae type b (Hib) disease is a serious disease caused by a bacteria.... | Haemophilus influenzae Type b (Hib) Vaccine (patient information)
For the WikiDoc page for Haemophilus influenzae infection, click here
For patient information about Haemophilus influenzae infection, click here
Template:Drug header
# What is Hib disease
Haemophilus influenzae type b (Hib) disease is a serious disease... | https://www.wikidoc.org/index.php/Haemophilus_Influenzae_Type_b_(Hib)_Vaccine_(patient_information) | |
af5544eaf44f5b20af0da8970f426fc34db66c37 | wikidoc | Hyperlipoproteinemia natural history, complications and prognosis | Hyperlipoproteinemia natural history, complications and prognosis
# Overview
Hyperlipidemia may be inherited or secondary to some underlying disorder. Without treatment, it progresses to cause cardiovascular and cerebrovascular diseases. However, early detection and aggressive management to lower the blood lipid level... | Hyperlipoproteinemia natural history, complications and prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hardik Patel, M.D.
# Overview
Hyperlipidemia may be inherited or secondary to some underlying disorder. Without treatment, it progresses to cause cardiovascular and cere... | https://www.wikidoc.org/index.php/Hyperlipoproteinemia_natural_history,_complications_and_prognosis | |
7f6aa075818c996ca2b6de37eb33a40af5388cc8 | wikidoc | Jawaharlal Institute of Postgraduate Medical Education & Research | Jawaharlal Institute of Postgraduate Medical Education & Research
The Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER) is a premier medical institute of India located in Puducherry (formerly Pondicherry), a town in southern India that lies on the shores of the Bay of Bengal. JIPMER is both an ... | Jawaharlal Institute of Postgraduate Medical Education & Research
Template:Infobox Medical College
The Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER) is a premier medical institute of India located in Puducherry (formerly Pondicherry), a town in southern India that lies on the shores of the... | https://www.wikidoc.org/index.php/Jawaharlal_Institute_of_Postgraduate_Medical_Education_%26_Research | |
a1268f8f5fd68ed4705187bb92fbc963eae1525f | wikidoc | List of ICD-9 codes 580-629: Diseases of the genitourinary system | List of ICD-9 codes 580-629: Diseases of the genitourinary system
# 10. Diseases of the genitourinary system (580-629)
## nephritis, nephrotic syndrome, and nephrosis (580-589)
- (580) Acute glomerulonephritis
(580.9) Glomerulonephritis, acute, unspec.
- (580.9) Glomerulonephritis, acute, unspec.
- (581) Nephrotic sy... | List of ICD-9 codes 580-629: Diseases of the genitourinary system
# 10. Diseases of the genitourinary system (580-629)
## nephritis, nephrotic syndrome, and nephrosis (580-589)
- (580) Acute glomerulonephritis
(580.9) Glomerulonephritis, acute, unspec.
- (580.9) Glomerulonephritis, acute, unspec.
- (581) Nephrotic sy... | https://www.wikidoc.org/index.php/List_of_ICD-9_codes_580-629:_Diseases_of_the_genitourinary_system | |
1126c2d8f6bef4acf65d30384ab484ba7bc45961 | wikidoc | Neomycin, polymyxin, and bacitracin topical (patient information) | Neomycin, polymyxin, and bacitracin topical (patient information)
# Why is this medication prescribed
Neomycin, polymyxin, and bacitracin combination is used to prevent minor skin injuries such as cuts, scrapes, and burns from becoming infected. Neomycin, polymyxin, and bacitracin are in a class of medications called ... | Neomycin, polymyxin, and bacitracin topical (patient information)
Template:Drug header
# Why is this medication prescribed
Neomycin, polymyxin, and bacitracin combination is used to prevent minor skin injuries such as cuts, scrapes, and burns from becoming infected. Neomycin, polymyxin, and bacitracin are in a class ... | https://www.wikidoc.org/index.php/Neomycin,_polymyxin,_and_bacitracin_topical | |
a2e25f49f78d2f80c49e5b5a0cf61efc45f5abdd | wikidoc | Nitroglycerin Tablets, Capsules, and Sprays (patient information) | Nitroglycerin Tablets, Capsules, and Sprays (patient information)
# Why this medication is prescribed
Nitroglycerin is used to prevent chest pain (angina). It works by relaxing the blood vessels to the heart, so the blood flow and oxygen supply to the heart is increased.
This medication is sometimes prescribed for oth... | Nitroglycerin Tablets, Capsules, and Sprays (patient information)
Template:Drug header
# Why this medication is prescribed
Nitroglycerin is used to prevent chest pain (angina). It works by relaxing the blood vessels to the heart, so the blood flow and oxygen supply to the heart is increased.
This medication is someti... | https://www.wikidoc.org/index.php/Nitroglycerin_(patient_information) | |
4b28e2347703e41039de5ce52c271cba82b21bb9 | wikidoc | Solitary pulmonary nodule evaluation of solitary pulmonary nodule | Solitary pulmonary nodule evaluation of solitary pulmonary nodule
# Overview
A hallmark feature in the evaluation of pulmonary nodule is the malignancy risk assessment. The evaluation approach for pulmonary nodule will mainly depend in the initial morphological evaluation of the nodule (size, margins, contours, and gr... | Solitary pulmonary nodule evaluation of solitary pulmonary nodule
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
# Overview
A hallmark feature in the evaluation of pulmonary nodule is the malignancy risk assessment. The evaluation approach for pulmo... | https://www.wikidoc.org/index.php/Solitary_pulmonary_nodule_evaluation_of_solitary_pulmonary_nodule | |
2d5639ae0256c55738cc308f19cea7943f6972bc | wikidoc | Standard views and measurements in transthoracic echocardiography | Standard views and measurements in transthoracic echocardiography
# Overview
# Nomenclature
- Each image is defined by the position of the transducer and the image plane
Transducer location
Parasternal
Apical
Subcostal
Suprasternal
Image plane
Vertical Long axis: parallel to the long axis of the left ventricle (2 cha... | Standard views and measurements in transthoracic echocardiography
Editors-in-chief: Eli V. Gelfand, MD; Anne B. Riley, MD (Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, respectively)
# Overview
# Nomenclature
- Each imag... | https://www.wikidoc.org/index.php/Standard_Transthoracic_Views_and_Measurements | |
59c00b87755b104c28aa2cdd1b627eea868d4da7 | wikidoc | Valproic acid capsule delayed release use in specific populations | Valproic acid capsule delayed release use in specific populations
# Use In Specific Populations
### 8.1 Pregnancy
Pregnancy Category D for epilepsy and for manic episodes associated with bipolar disorder .
Pregnancy Category X for prophylaxis of migraine headaches .
To collect information on the effects of in utero e... | Valproic acid capsule delayed release use in specific populations
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# Use In Specific Populations
### 8.1 Pregnancy
Pregnancy Category D for epilepsy and for manic episodes associated with bipolar disorder [see Warnings and Precautions (5.3 and 5.3)].
Pregnancy Catego... | https://www.wikidoc.org/index.php/Valproic_acid_capsule_delayed_release_use_in_specific_populations | |
fdaca4e498f14fe39db0eda3e7e5ebccf1e73e99 | wikidoc | World Health Organization Framework Convention on Tobacco Control | World Health Organization Framework Convention on Tobacco Control
The World Health Organization Framework Convention on Tobacco Control (abbreviated WHO FCTC) is a treaty adopted unanimously by the 56th World Health Assembly on May 21, 2003. It became the first World Health Organization treaty adopted under article 19 ... | World Health Organization Framework Convention on Tobacco Control
The World Health Organization Framework Convention on Tobacco Control (abbreviated WHO FCTC) is a treaty adopted unanimously by the 56th World Health Assembly on May 21, 2003.[1] It became the first World Health Organization treaty adopted under article... | https://www.wikidoc.org/index.php/WHO_Framework_Convention_on_Tobacco_Control | |
e3b90d7d34ce3d19d8c355b79c8c550cdfd11af2 | wikidoc | Wild-type (senile) ATTR amyloidosis epidemiology and demographics | Wild-type (senile) ATTR amyloidosis epidemiology and demographics
# Overview
The incidence of amyloidosis is approximately 1.2 per 100,000 individuals per year worldwide. The mortality rate of systemic amyloidosis is approximately 100 per 100,000 deaths in developed countries. In amyloidosis, the mean age of presenta... | Wild-type (senile) ATTR amyloidosis epidemiology and demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2] Fahimeh Shojaei, M.D.
# Overview
The incidence of amyloidosis is approximately 1.2 per 100,000 individuals per year worldwide. The mortality ... | https://www.wikidoc.org/index.php/Wild-type_(senile)_ATTR_amyloidosis_epidemiology_and_demographics | |
fc7bc6889ad7ef6349c45f5b1db71d08e980e2b1 | wikidoc | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha 1 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha 1
ATP synthase subunit alpha, mitochondrial is an enzyme that in humans is encoded by the ATP5A1 gene.
# Function
This gene encodes a subunit of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis, using an electrochemical gradie... | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha 1
ATP synthase subunit alpha, mitochondrial is an enzyme that in humans is encoded by the ATP5A1 gene.[1][2]
# Function
This gene encodes a subunit of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis, using an electrochemical... | https://www.wikidoc.org/index.php/ATP_synthase,_H%2B_transporting,_mitochondrial_F1_complex,_alpha_1 | |
c4bf8fedac1d58d09a10e79e3482a0f3838c3848 | wikidoc | Aluminum Hydroxide and Magnesium Hydroxide (patient information) | Aluminum Hydroxide and Magnesium Hydroxide (patient information)
# Why this medication is prescribed
Aluminum hydroxide and magnesium hydroxide are antacids used together to relieve heartburn, acid indigestion, and stomach upset. They may be used to treat these symptoms in patients with peptic ulcer, gastritis, esopha... | Aluminum Hydroxide and Magnesium Hydroxide (patient information)
Template:Drug header
# Why this medication is prescribed
Aluminum hydroxide and magnesium hydroxide are antacids used together to relieve heartburn, acid indigestion, and stomach upset. They may be used to treat these symptoms in patients with peptic ul... | https://www.wikidoc.org/index.php/Aluminum_Hydroxide_and_Magnesium_Hydroxide | |
804c3662c3a1dbbba121b2e5bf98c564a105eef5 | wikidoc | CT Angiography in the Assessment of Saphenous Vein Graft Disease | CT Angiography in the Assessment of Saphenous Vein Graft Disease
There is interest in the non-invasive assessment of SVG patency using CT imaging. In a recent study that used SVG patency as the primary endpoint, 224/249 (90.3%) of patients returned for follow-up CT at 3 months. There were 704 grafts in these 224 p... | CT Angiography in the Assessment of Saphenous Vein Graft Disease
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
There is interest in the non-invasive assessment of SVG patency using CT imaging. In a recent study that used SVG patency as the primary endpoint, 224/249 (90.3%) of patients returned for follow-up CT... | https://www.wikidoc.org/index.php/CT_Angiography_in_the_Assessment_of_Saphenous_Vein_Graft_Disease | |
d056efeaf4ae4974b56df1e3c821b92304d1ee3a | wikidoc | Differentiating systemic lupus erythematosus from other diseases | Differentiating systemic lupus erythematosus from other diseases
# Overview
Systemic lupus erythematosus (SLE) must be differentiated from other diseases that cause skin rash, arthritis, positive autoimmune serology, weight loss, fevers and chronic pain, such as rheumatoid arthritis (RA), mixed connective tissue disea... | Differentiating systemic lupus erythematosus from other diseases
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]
# Overview
Systemic lupus erythematosus (SLE) must be differentiated from other diseases that cause skin rash, arthritis, positive autoimmune serolo... | https://www.wikidoc.org/index.php/Differentiating_systemic_lupus_erythematosus_from_other_diseases | |
fb4963e49c46cdd668099a7e155720b1cb024889 | wikidoc | Fluticasone and Salmeterol Oral Inhalation (patient information) | Fluticasone and Salmeterol Oral Inhalation (patient information)
# IMPORTANT WARNING
In a large clinical study more patients with asthma who used salmeterol died of asthma problems than patients with asthma who did not use salmeterol. If you have asthma, use of salmeterol may increase the risk that you will develop se... | Fluticasone and Salmeterol Oral Inhalation (patient information)
Template:Drug header
# IMPORTANT WARNING
In a large clinical study more patients with asthma who used salmeterol died of asthma problems than patients with asthma who did not use salmeterol. If you have asthma, use of salmeterol may increase the risk th... | https://www.wikidoc.org/index.php/Fluticasone_and_Salmeterol | |
d9af886dbc747d54a02987d0d28f8e59a62e8fcd | wikidoc | Hantavirus cardiopulmonary syndrome (HCPS) (patient information) | Hantavirus cardiopulmonary syndrome (HCPS) (patient information)
For the WikiDoc page for this topic, click here
# Overview
Hantavirus Pulmonary Syndrome (HPS) is a severe, sometimes fatal, respiratory disease in humans caused by infection with a hantavirus. Anyone who comes into contact with rodents that carry hantav... | Hantavirus cardiopulmonary syndrome (HCPS) (patient information)
For the WikiDoc page for this topic, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
# Overview
Hantavirus Pulmonary Syndrome (HPS) is a severe, sometimes fatal, respiratory diseas... | https://www.wikidoc.org/index.php/Hantavirus_cardiopulmonary_syndrome_(HCPS)_(patient_information) | |
c9de6e6e899638bedfa41b40948914b70fcaaca5 | wikidoc | ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases | ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases
# E00-E35 - Endocrine diseases
## (E00-E07) Thyroid gland / Thyroid hormone
- (E00) Congenital iodine-deficiency syndrome
- (E01) Iodine-deficiency-related thyroid disorders and allied conditions
(E01.0) Iodine-deficiency-related diffuse (endemic) goitr... | ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# E00-E35 - Endocrine diseases
## (E00-E07) Thyroid gland / Thyroid hormone
- (E00) Congenital iodine-deficiency syndrome
- (E01) Iodine-deficiency-related thyroid disorders and allied conditions
(E01.... | https://www.wikidoc.org/index.php/ICD-10_Chapter_IV:_Endocrine,_nutritional_and_metabolic_diseases | |
e0fc15adfd69a3bca25bdf59c915697d127bd600 | wikidoc | ICD-10 Chapter XII: Diseases of the skin and subcutaneous tissue | ICD-10 Chapter XII: Diseases of the skin and subcutaneous tissue
# L00-L99 - Diseases of the skin and subcutaneous tissue
## (L00-L08) Infections of the skin and subcutaneous tissue
- (L00) Staphylococcal scalded skin syndrome
- (L01) Impetigo
- (L02) Cutaneous abscess, furuncle and carbuncle
- (L03) Cellulitis
(L03.... | ICD-10 Chapter XII: Diseases of the skin and subcutaneous tissue
# L00-L99 - Diseases of the skin and subcutaneous tissue
## (L00-L08) Infections of the skin and subcutaneous tissue
- (L00) Staphylococcal scalded skin syndrome
- (L01) Impetigo
- (L02) Cutaneous abscess, furuncle and carbuncle
- (L03) Cellulitis
(L03.... | https://www.wikidoc.org/index.php/ICD-10_Chapter_L | |
8cb40696eab138f745ad12ee87f54018813dd211 | wikidoc | Interferon beta-1a Intramuscular Injection (patient information) | Interferon beta-1a Intramuscular Injection (patient information)
# Why this medication is prescribed
Interferon beta-1a is used to decrease the number of episodes of symptoms and slow the development of disability in patients with relapsing-remitting (symptoms come and go) multiple sclerosis (MS, a disease in which th... | Interferon beta-1a Intramuscular Injection (patient information)
Template:Drug header
# Why this medication is prescribed
Interferon beta-1a is used to decrease the number of episodes of symptoms and slow the development of disability in patients with relapsing-remitting (symptoms come and go) multiple sclerosis (MS,... | https://www.wikidoc.org/index.php/Interferon_beta-1a_Intramuscular | |
1b5b6469d943964bbd2f8c66511e37a8d98b83a0 | wikidoc | Just heard say he would put black and silver on his pod moves 96 | Just heard say he would put black and silver on his pod moves 96
Difficulty:
Moderately Challenging
Instructions
1 Learn on gold and silver bullion. There are any large quantity of bullion products besides the commonly traded gold or silver U.S. American Eagles, Canadian Maple Departs, also the South African Krugerrand... | Just heard say he would put black and silver on his pod moves 96
Difficulty:
Moderately Challenging
Instructions
1 Learn on gold and silver bullion. There are any large quantity of bullion products besides the commonly traded gold or silver U.S. American Eagles, Canadian Maple Departs, also the South African Krugerran... | https://www.wikidoc.org/index.php/Just_heard_say_he_would_put_black_and_silver_on_his_pod_moves_96 | |
b9293281eec6a273872fedd14649fce181c5c0ef | wikidoc | Major or mild neurocognitive disorder due to Alzheimer's disease | Major or mild neurocognitive disorder due to Alzheimer's disease
# Overview
# Major or Mild Neurocognitive Disorder Due to Alzheimer's Disease
## DSM-V Diagnostic Criteria for Major or Mild Neurocognitive Disorder Due to Alzheimer’s Disease
# Epidemiology and Demographics
## Prevalence
By age group, the prevalenc... | Major or mild neurocognitive disorder due to Alzheimer's disease
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]
# Overview
# Major or Mild Neurocognitive Disorder Due to Alzheimer's Disease
## DSM-V Diagnostic Criteria for Major or Mild Neurocognitive Disord... | https://www.wikidoc.org/index.php/Major_or_Mild_Neurocognitive_Disorder_Due_To_Alzheimer%27s_Disease | |
31244313d34d1f5c37e02c12267eb27d8e97e8d9 | wikidoc | Major or mild neurocognitive disorder due to Parkinson's disease | Major or mild neurocognitive disorder due to Parkinson's disease
# Overview
Cognitive impairment and dementia can occur in the PD but in some ways it’s different from Alzheimer disease. Language dysfunction and memory deficit is less prominent while executive and visuospatial dysfunction is more prominent in PD. Parki... | Major or mild neurocognitive disorder due to Parkinson's disease
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
# Overview
Cognitive impairment and dementia can occur in the PD but in some ways it’s different from Alzheimer disease. Language dysfunction and me... | https://www.wikidoc.org/index.php/Major_or_mild_neurocognitive_disorder_due_to_Parkinson%27s_disease | |
0ac28856e3e9c37c2f20f40a40e91947cd8d7c55 | wikidoc | Natural orifice translumenal endoscopic surgery (NOTES) | Natural orifice translumenal endoscopic surgery (NOTES) overview
For the WikiPatient page for this topic, click here
Synonyms and keywords: Natural orifice translumenal endoscopic surgery, Single incision laparoscopic surgery, Minimally invasive surgery, Transanal endoscopic microsurgery, Natural orifice surgery consor... | Natural orifice translumenal endoscopic surgery (NOTES) overview
For the WikiPatient page for this topic, click here
Editor-In-Chief: Mohammed A. Sbeih, M.D. [1]Phone: 617-849-2629; Assistant Editor-In-Chief: Kristin Feeney, B.S. [2]
Synonyms and keywords: Natural orifice translumenal endoscopic surgery, Single incisi... | https://www.wikidoc.org/index.php/Natural_orifice_translumenal_endoscopic_surgery_(NOTES)_overview | |
641d0eb5be14db4585abb7f85afcc921d3c46b62 | wikidoc | Pacemaker insertion discharge instructions (patient information) | Pacemaker insertion discharge instructions (patient information)
# Overview
You had a pacemaker placed in your chest to help your heart beat properly.
- A small cut was made on your chest below your collarbone. The pacemaker generator was then placed under the skin at this location.
- Leads (wires) were connected to t... | Pacemaker insertion discharge instructions (patient information)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Mohammed A. Sbeih, M.D. [2]
# Overview
You had a pacemaker placed in your chest to help your heart beat properly.
- A small cut was made on your chest below your collarbone.... | https://www.wikidoc.org/index.php/Pacemaker_discharge_instructions_(patient_information) | |
02f2630d35c06f268c68e9c676de490645d8c27f | wikidoc | Paroxysmal AV Block Natural History, Complications and Prognosis | Paroxysmal AV Block Natural History, Complications and Prognosis
# Overview
Natural history most commonly includes recurrent unexplained syncope and presyncope. Complications such as sudden cardian death or indefinite periods of asystole may arise. Prognosis of intrinsic paroxysmal AV block is more dire than extrinsic... | Paroxysmal AV Block Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]
# Overview
Natural history most commonly includes recurrent unexplained syncope and presyncope. Complications such as sudden cardian death or i... | https://www.wikidoc.org/index.php/Paroxysmal_AV_Block_Natural_History,_Complications_and_Prognosis | |
7f98e576d3e6a3f5f695561cf4ec147db182e2f2 | wikidoc | Penicillin G Potassium or Sodium Injection (patient information) | Penicillin G Potassium or Sodium Injection (patient information)
# About your treatment
Your doctor has ordered penicillin, an antibiotic, to help treat your infection. The drug will be either injected into a large muscle (such as your buttock or hip) or added to an intravenous fluid that will drip through a needle or... | Penicillin G Potassium or Sodium Injection (patient information)
Template:Drug header
# About your treatment
Your doctor has ordered penicillin, an antibiotic, to help treat your infection. The drug will be either injected into a large muscle (such as your buttock or hip) or added to an intravenous fluid that will dr... | https://www.wikidoc.org/index.php/Penicillin_G_Potassium_or_Sodium | |
f48d4fae13247fa104aa9762e960e8f787e83bc3 | wikidoc | Prevention: Results of the ILLUMINATE Trial Released at AHA 2007 | Prevention: Results of the ILLUMINATE Trial Released at AHA 2007
November 6, 2007 By Scott P. Williams
Orlando, FL: The results of the ILLUMINATE trial suggest that patients with a history of cardiovascular disease (CVD) who are treated with torcetrapib face an increased risk of death and cardiac events. The results ... | Prevention: Results of the ILLUMINATE Trial Released at AHA 2007
November 6, 2007 By Scott P. Williams [1]
Orlando, FL: The results of the ILLUMINATE trial suggest that patients with a history of cardiovascular disease (CVD) who are treated with torcetrapib face an increased risk of death and cardiac events. The resu... | https://www.wikidoc.org/index.php/Prevention:_Results_of_the_ILLUMINATE_Trial_Released_at_AHA_2007 | |
14a4f66c66bc958a52163d85ef4c72e5f38ae0c0 | wikidoc | Segmental echocardiographic approach to congenital heart disease | Segmental echocardiographic approach to congenital heart disease
# Evaluation of cardiac anatomy
Echocardiographic evaluation of congenital heart disease requires segmental and systematic approach.
# 1. Assess atrial situs
- Subcostal views are optimal
- Situs Solitus= Normal anatomy (morphologic right atrium is to t... | Segmental echocardiographic approach to congenital heart disease
Editors: Eli V. Gelfand, MD and Keri Shafer, MD (Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA)
# Evaluation of cardiac anatomy
Echocardiographic evaluation of congenital heart disease requires segmental and systematic approac... | https://www.wikidoc.org/index.php/Segmental_echocardiographic_approach_to_congenital_heart_disease |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.